Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

WSE/PUR stock hub

WSE/PUR has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

WSE/PURis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
29.5M
Warsaw Stock Exchange
Market data

Price

Recent price action with selectable time range.

WSE/PURWSE/PUR
Loading chart…
In the news

Latest news · WSE/PUR

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 n/aP50 n/aP75 n/a
Trailing P/En/a
P25 n/aP50 n/aP75 n/a
ROEn/a
P25 n/aP50 n/aP75 n/a
ROIC-323.1
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All WSE/PUR market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
138
Groups with data
11
Currency
PLN
Showing 138 of 138 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

19
MetricValue
Country
Poland
Country code
PL
Employees
6
Employees Change
2%
Employees Change Percent
50
Enterprise value
PLN 44.4M
Exchange
Warsaw Stock Exchange
Financial currency
PLN
First seen
2026-05-10
Industry
Biotechnology
Isin
PLPRBLG00010
Last refreshed
2026-05-10
Market cap
PLN 29.5M
Price
PLN 2.41
Price currency
PLN
Sector
Healthcare
Sic
2836
Symbol
wse/PUR
Website
https://purebiologics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

3
MetricValue
Earnings Yield
-60.75%
EV Earnings
-2.47x
P/B ratio
-1.52x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

8
MetricValue
Gross Profit
PLN -30,000
Net Income
PLN -17.9M
Net Income Growth Years
1%
Profit Per Employee
PLN -3M
ROA
-116.3
Roa5y
-34.6
ROCE
58.19
ROIC
-323.1

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

6
MetricValue
Cagr1y
-38.91%
Cagr3y
-31.01%
Cagr5y
-44.65%
EPS Growth Quarters
7
EPS Growth Years
2
Revenue Growth Years
0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

15
MetricValue
Assets
PLN 1.3M
Cash
PLN 112,000
Current Assets
PLN 1.3M
Current Liabilities
PLN 20.7M
Debt
PLN 15M
Equity
PLN -19.4M
Interest Coverage
-5.88
Liabilities
PLN 20.7M
Long Term Assets
PLN 12,000
Long Term Liabilities
PLN 0
Net Cash
PLN -14.9M
Net Cash By Market Cap
PLN -50.36
Tangible Book Value
PLN -19.4M
Tangible Book Value Per Share
PLN -4.75
WACC
7.62

Liquidity

Current-asset coverage and working-capital efficiency metrics.

4
MetricValue
Current ratio
0.06
Net Working Capital
PLN -4.5M
Quick ratio
0.05
Working Capital
PLN -19.4M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-18.06%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

37
MetricValue
1Y total return
-38.89%
200-day SMA
4.63
3Y total return
-67.18%
50-day SMA
2.47
50-day SMA vs 200-day SMA
50under200
5Y total return
-94.8%
All Time High
152
All Time High Change
-98.41%
All Time High Date
2020-08-05
All Time Low
1.35
All Time Low Change
78.12%
All Time Low Date
2026-03-23
ATR
0.28
Beta
0.38
Beta1y
0.22
Beta2y
-0.73
Ch YTD
-32.34
High
2.41
High52
9.2
High52 Date
2025-07-29
High52ch
-73.8%
Low
2.41
Low52
1.35
Low52 Date
2026-03-23
Low52ch
78.12%
Ma50ch
-2.59%
Price vs 200-day SMA
-47.99%
RSI
44.54
RSI Monthly
30.7
RSI Weekly
37.72
Sharpe ratio
0.3x
Sortino ratio
0.67
Total Return
-18.06%
Tr YTD
-32.34
Tr1m
2.99%
Tr1w
-9.91%
Tr3m
-32.91%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

1
MetricValue
Operating Income
PLN -11.3M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
11,805,777%
Net Borrowing
4,330,000
Shares Insiders
3.58%
Shares Institutions
0.5%
Shares Out
12,244,716
Shares Qo Q
-0.11%
Shares Yo Y
18.06%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

37
MetricValue
Average Volume
470,294.55x
Bv Per Share
-4.75
Ch1m
2.99
Ch1w
-9.91
Ch1y
-73.76
Ch3m
-32.91
Ch3y
-85.91
Ch5y
-97.77
Ch6m
-58.16
Change
0%
Change From Open
0
Close
2.41
Days Gap
0
Depreciation Amortization
140,000
Earnings Date
2026-04-30
EBIT
PLN -11.3M
EBITDA
PLN -11.1M
EPS
PLN -4.52
F Score
1
Financing CF
3,706,000
Fiscal Year End
December
Founded
2,010
Investing CF
240,000
Is Primary Listing
1
Last Earnings Date
2026-04-30
Last Report Date
2025-09-30
Ma150
4.02
Ma150ch
-40.03%
Ma20
2.7
Ma20ch
-10.77%
Net CF
-1,169,000
Next Earnings Date
2026-05-15
Open
2.41
Price Date
2026-05-07
Relative Volume
0.31x
Tr6m
-58.16%
Volume
0
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does WSE/PUR pay a dividend?

Capital-return profile for this ticker.

Performance

WSE/PUR stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-38.9%
S&P 500 1Y: n/a
3Y total return
-67.2%
S&P 500 3Y: n/a
5Y total return
-94.8%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns WSE/PUR?

Insider, institutional, and short-interest positioning.

Institutional ownership
+0.5%
Share of float held by funds and institutions
Insider ownership
+3.6%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+18.1%
Negative means the company is buying back shares.
Technical

WSE/PUR momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
44.5
Neutral momentum band
Price vs 200-day MA
-48.0%
50/200-day relationship not available
Beta (5Y)
0.38
Less volatile than the market
Sharpe ratio
0.30
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About WSE/PUR

Hub-level FAQ points readers to the deeper analysis pages.

What is the current wse/PUR stock rating?

wse/PUR is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full wse/PUR analysis?

The full report lives at /stocks/wse/PUR/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for wse/PUR?

The latest report frames wse/PUR around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the wse/PUR page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.